{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:57:49Z","timestamp":1775289469203,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1987,9]]},"DOI":"10.1016\/0002-9343(87)90751-0","type":"journal-article","created":{"date-parts":[[2004,6,21]],"date-time":"2004-06-21T08:43:01Z","timestamp":1087807381000},"page":"425-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Inefficacy of pneumococcal vaccine in a high-risk population"],"prefix":"10.1016","volume":"83","author":[{"given":"Heather L.","family":"Forrester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis W.","family":"Jahnigen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Marc Laforce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(87)90751-0_BIB1","first-page":"11","article-title":"Guide for adult immunization","year":"1985"},{"key":"10.1016\/0002-9343(87)90751-0_BIB2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-96-2-203","article-title":"Pneumococcal polysaccharide vaccine","volume":"96","author":"Centers for Disease Control","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB3","first-page":"410","article-title":"Recommendations of the ACIP for the Pneumococcal Polysaccharide Vaccine","volume":"30","year":"1981","journal-title":"Morbid Mortal Weekly Rep"},{"key":"10.1016\/0002-9343(87)90751-0_BIB4_1","series-title":"Pneumococcal polysaccharide vaccine usage\u2014United States","first-page":"3071","volume":"251","year":"1984"},{"key":"10.1016\/0002-9343(87)90751-0_BIB4_2","series-title":"Pneumococcal polysaccharide vaccine usage\u2014United States","first-page":"3075","volume":"251","year":"1984"},{"key":"10.1016\/0002-9343(87)90751-0_BIB5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7326\/0003-4819-96-2-208","article-title":"Pneumococcal vaccine: clinical efficacy and effectiveness","volume":"96","author":"Schwartz","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB6","first-page":"572","article-title":"The current status of polyvalent pneumococcal vaccine","volume":"6","author":"Austrian","year":"1984","journal-title":"Clin Ther"},{"key":"10.1016\/0002-9343(87)90751-0_BIB7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.1981.03320130034020","article-title":"Pneumococcal vaccine in the United States: a critical analysis","volume":"246","author":"Hirschmann","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/0002-9343(87)90751-0_BIB8","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1093\/clinids\/3.Supplement_1.S82","article-title":"Efficacy of pneumococcal polysaccharide vaccine","volume":"3","author":"Broome","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(87)90751-0_BIB9","series-title":"Are there alternatives to randomized clinical trials?","first-page":"589","article-title":"Resolving the pneumococcal vaccine controversy","volume":"6","author":"Clemens","year":"1984"},{"key":"10.1016\/0002-9343(87)90751-0_BIB10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-104-1-106","article-title":"Pneumococcal vaccine and patients with chronic lung disease: a critical perspective","volume":"104","author":"Williams","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB11","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/clinids\/3.Supplement_1.S61","article-title":"Pneumococcal vaccine in the institutionalized elderly: review of past and recent studies","volume":"3","author":"Bentley","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(87)90751-0_BIB12","first-page":"184","article-title":"Prevention of pneumococcal pneumonia by vaccination","volume":"89","author":"Austrian","year":"1976","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/0002-9343(87)90751-0_BIB13","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03280250039019","article-title":"Protective efficacy of pneumococcal polysaccharide vaccines","volume":"238","author":"Smit","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/0002-9343(87)90751-0_BIB14","first-page":"1","article-title":"Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccine (report DAB-VDP-12-84)","author":"Austrian","year":"1980"},{"key":"10.1016\/0002-9343(87)90751-0_BIB15","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1093\/clinids\/3.Supplement_1.S184","article-title":"Assessment of the antibody response to pneumococcal vaccine in high-risk populations","volume":"3","author":"Landesman","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(87)90751-0_BIB16","first-page":"312","article-title":"The antibody response to pneumococcal capsular polysaccharide in aged individuals","volume":"164","author":"Ammann","year":"1980"},{"key":"10.1016\/0002-9343(87)90751-0_BIB17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-101-3-325","article-title":"A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections","volume":"101","author":"Shapiro","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198009043031003","article-title":"Pneumococcal vaccination\u2014an alternative method to estimate the efficacy of pneumococcal vaccine","volume":"303","author":"Broome","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-104-1-1","article-title":"Pneumococcal vaccine efficacy in selected populations in the United States","volume":"104","author":"Bolan","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-9343(83)91191-9","article-title":"Effect of underlying disease and age on pneumococcal serotype distributions","volume":"75","author":"Weisholtz","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/clinids\/3.2.277","article-title":"Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States","volume":"3","author":"Broome","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(87)90751-0_BIB22","series-title":"Relevance of composition of the pneumococcal vaccine","first-page":"263","article-title":"Pneumococcal serotypes causing bacteremia and meningitis","volume":"125","author":"Dixon","year":"1981"},{"key":"10.1016\/0002-9343(87)90751-0_BIB23","series-title":"Correlations with age, outcome, and indications for vaccination","first-page":"737","article-title":"Serogroups and serotypes of pneumococci in Montreal","volume":"130","author":"Lamothe","year":"1984"},{"key":"10.1016\/0002-9343(87)90751-0_BIB24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/infdis\/148.6.1136","article-title":"Considerations for formulating the second generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups","volume":"148","author":"Robbins","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/0002-9343(87)90751-0_BIB25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(80)91887-5","article-title":"Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease","volume":"II","author":"Addiego","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/0002-9343(87)90751-0_BIB26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7326\/0003-4819-90-6-887","article-title":"Response of patients with Hodgkin's disease to pneumococcal vaccine","volume":"90","author":"Minor","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9343(80)90014-5","article-title":"Pneumococcal vaccination: the response of patients with multiple myeloma","volume":"69","author":"Lazarus","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB28","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.1981.00340130081018","article-title":"Response to pneumococcal vaccine in hemodialysis and renal transplant patients","volume":"141","author":"Linneman","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB29","first-page":"101","article-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"key":"10.1016\/0002-9343(87)90751-0_BIB30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198611203152104","article-title":"Efficacy of pneumococcal vaccine in high-risk patients","volume":"315","author":"Simberkoff","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-9343(87)90751-0_BIB31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/0003-4819-104-1-110","article-title":"Pneumococcal vaccine: the evidence mounts","volume":"104","author":"Laforce","year":"1986","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934387907510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934387907510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:26:35Z","timestamp":1756884395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002934387907510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["0002934387907510"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(87)90751-0","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1987,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inefficacy of pneumococcal vaccine in a high-risk population","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(87)90751-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1987 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}